Last Updated: November 8, 2026

Piramal Company Profile

« Back to Dashboard

What is the competitive landscape for PIRAMAL

PIRAMAL has twenty approved drugs.

Summary for Piramal

US Patents:	0
Tradenames:	18
Ingredients:	18
NDAs:	20

Drugs and US Patents for Piramal

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Piramal Critical	GABLOFEN	baclofen	INJECTABLE;INTRATHECAL	022462-001	Nov 19, 2010	AP	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Piramal Critical	MITIGO	morphine sulfate	INJECTABLE;INJECTION	204393-001	Jul 16, 2018	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Piramal	CINACALCET HYDROCHLORIDE	cinacalcet hydrochloride	TABLET;ORAL	210207-003	Aug 1, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Piramal	TETRABENAZINE	tetrabenazine	TABLET;ORAL	213316-002	Jan 22, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Piramal Critical	GABLOFEN	baclofen	INJECTABLE;INTRATHECAL	022462-003	Nov 19, 2010	AP	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Piramal Critical	OXACILLIN SODIUM	oxacillin sodium	INJECTABLE;INJECTION	206681-001	Sep 11, 2017		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Piramal	RANOLAZINE	ranolazine	TABLET, EXTENDED RELEASE;ORAL	213085-002	Jul 25, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for PIRAMAL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.